Joel Kaye
Inventor
Stats
- 4 US patents issued
- 33 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 4 US Patents Issued
- 33 US Applications Filed
- 122 Total Citation Count
- Sep 12, 2022 Most Recent Filing
- Jul 29, 2010 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| UOP LLC | 1
1 | 2014
2016 |
| TEVA PHARMACEUTICAL INDUSTRIES LTD. | 2
2 5 2 2 4 8 | 2010
2011 2013 2014 2015 2016 2017 |
| CEPHALON, INC. | 1
| 2014
|
| ONCOGENEX TECHNOLOGIES INC. | 2
| 2014
|
Inventor Addresses
| Address | Duration |
|---|---|
| Long Grove, IL, US | Jun 16, 16 - Nov 13, 18 |
| Netanya, IL | Feb 03, 11 - Jan 28, 25 |
| Netanya, IL, US | Aug 18, 16 - Aug 18, 16 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 31 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 8 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 12208091 | 2025 | Compounds for treatment of eye diseases associated with excessive vascularisation | 0 |
| 2024/0299,411 | 2024 | COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS FOR TREATING CANCER | 0 |
| 2023/0381,196 | 2023 | COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS FOR TREATING ADENOID CYSTIC CARCINOMA | 0 |
| 11654140 | 2023 | Treatment of ocular inflammatory diseases using laquinimod | 0 |
| 2023/0066,364 | 2023 | Compounds for Treatment of Eye Diseases Associated With Excessive Vascularisation | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.